Immucor Inc  (BLUD)     Rate BLUD  -  Discuss BLUD  -  Add to Watch List        

Filed under: Earnings reports, Technical Analysis, Stocks to Buy

Immucor (NASDAQ: BLUD) provides automated systems used by hospitals, clinical laboratories and blood banks to detect and identify certain properties of the cell and serum components of human blood prior to transfusion. Products are primarily used to type blood and detect foreign antibodies. Immucor sells its systems and reagent tests directly in North America, Western Europe and Japan.

The company made news earlier in the week, when it reported Q3 EPS of 27 cents and revenues of $67.3 million. Analysts had been looking for 22 ce

Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website.

With the market acting a little more reasonable today, I wanted to find a stock that fit my criteria that I could share with all of you. Going to my usual 'first step' in identifying stocks, I noted that Immucor (BLUD) had made the list of top % gainers on the Nasdaq to

A few moments ago my Immucor (BLUD) stock hit a sale point at an (8)% loss. I sold 154 shares at $34.90. These shares were purchased only a couple of weeks ago, on October 4, 2007, at a cost basis of $38.02. Thus, I had a loss of $(3.12)/share or (8.2)% since purchase.

Sinc

Looking through the list